SCHEMBL14965210

SCHEMBL14965210

Nc1ncc2c(-c3ccccc3)csc2n1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADORA1 P30542 6/20 0.50
ADORA2A P29274 6/20 0.50
DAPK3 O43293 1/20 0.50
PRKD3 O94806 1/20 0.50
MAP4K4 O95819 1/20 0.50
ABL1 P00519 1/20 0.50
NTRK1 P04629 1/20 0.50
LCK P06239 1/20 0.50
CSF1R P07333 1/20 0.50
RET P07949 1/20 0.50
MET P08581 1/20 0.50
PDGFRB P09619 1/20 0.50
FGFR1 P11362 1/20 0.50
PDGFRA P16234 1/20 0.50
PRKACA P17612 1/20 0.50
FLT1 P17948 1/20 0.50
LTK P29376 1/20 0.50
KDR P35968 1/20 0.50
MAP2K2 P36507 1/20 0.50
MAPK8 P45983 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30341183 0.81 NPC1 (0.47) ADORA2ADAPK3PRKD3MAP4K4ABL1
SCHEMBL30341175 0.80 ALDH1A1 (0.46) DAPK3PRKD3MAP4K4ABL1NTRK1
SCHEMBL2368300 0.80 ESR1 (0.47) DAPK3PRKD3MAP4K4ABL1NTRK1
SCHEMBL2368688 0.76 FGFR1 (0.40) DAPK3PRKD3MAP4K4ABL1NTRK1
SCHEMBL16294388 0.76 DAPK3 (0.40) ADORA1ADORA2ADAPK3PRKD3MAP4K4
SCHEMBL2368935 0.76 ALDH1A1 (0.44) DAPK3PRKD3MAP4K4ABL1NTRK1
SCHEMBL30341174 0.76 LMNA (0.48) ADORA1ADORA2ADAPK3PRKD3MAP4K4
SCHEMBL2369195 0.76 DAPK3 (0.40) DAPK3PRKD3MAP4K4ABL1NTRK1
SCHEMBL2368984 0.76 FGFR1 (0.41) DAPK3PRKD3MAP4K4ABL1NTRK1
SCHEMBL14965048 0.75 CAMKK1 (0.41) ADORA1ADORA2ADAPK3PRKD3MAP4K4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230121698-A1 ECTONUCLEOTIDE PYROPHOSPHATASE/PHOSPHODIESTERASE 1 (ENPP1) MODULATORS AND USES THEREOF Sanford Burnham Prebys Medical Discovery Institute 2023-04-20 US disclosed
EP-2780343-A1 THIENO- AND FURO - PYRIMIDINES AND PYRIDINES, USEFUL AS POTASSIUM CHANNEL INHIBITORS Xention Limited (GB) 2014-09-24 EP disclosed
WO-2013072694-A1 THIENO- AND FURO - PYRIMIDINES AND PYRIDINES, USEFUL AS POTASSIUM CHANNEL INHIBITORS XENTION LIMITED (GB) 2013-05-23 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230121698-A1 ECTONUCLEOTIDE PYROPHOSPHATASE/PHOSPHODIESTERASE 1 (ENPP1) MODULATORS AND USES THEREOF ENPP1, ENPP3, PPA1 ADORA1 1610/4885ADORA2A 1054/4885DAPK3 1244/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.